Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION …
{{id}} {{{paragraph}}}
Example: air traffic controller
HIGHLIGHTS OF PRESCRIBING INFORMATION …
1. HIGHLIGHTS OF PRESCRIBING INFORMATION serious cardiac problems that may place them at increased These HIGHLIGHTS do not include all the INFORMATION needed to use vulnerability to its noradrenergic effects. Consideration should be STRATTERA safely and effectively. See full PRESCRIBING given to not using STRATTERA in adults with clinically significant INFORMATION for STRATTERA. cardiac abnormalities. ( ).. STRATTERA (atomoxetine) CAPSULES for Oral Use Emergent Cardiovascular Symptoms Patients should undergo Initial Approval: 2002 prompt cardiac evaluation. ( ). Effects on Blood Pressure and Heart Rate Increase in blood WARNING: SUICIDAL IDEATION IN CHILDREN AND pressure and heart rate; orthostasis and syncope may occur. Use ADOLESCENTS with caution in patients with hypertension, tachycardia, or See full PRESCRIBING INFORMATION for complete boxed warning.
3 The efficacy of STRATTERA Capsules was established in seven clinical trials in outpatients with ADHD: four 6 to 9-week trials in pediatric patients (ages6 to 18), two 10-week trial in adults, and one maintenance trial in pediatrics (ages
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: